NEW YORK (GenomeWeb News) – Danish gene expression company Exiqon has licensed real-time PCR-related technology from Roche Diagnostics, Roche said today.
Under the agreement, Roche has granted Exiqon a non-exclusive license to use the SYBR Green reagent for detecting and quantitating PCR products in real-time PCR reactions.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.